Lab Reagents

Cytomegalovirus Antibody Laboratories manufactures the cytomegalovirus antibod reagents distributed by Genprice. The Cytomegalovirus Antibod reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact cytomegalovirus Antibody. Other Cytomegalovirus products are available in stock. Specificity: Cytomegalovirus Category: Antibod

Test Assays information

Cytomegalovirus gB recombinant antigen
8965	Virostat	100 ug	EUR 608.1
Description: This is Cytomegalovirus gB recombinant antigen for ELISA,WB.

Cytomegalovirus p28 recombinant antigen
8966	Virostat	100 ug	EUR 608.1
Description: This is Cytomegalovirus p28 recombinant antigen for ELISA,WB.

Cytomegalovirus p150 recombinant antigen
8967	Virostat	100 ug	EUR 608.1
Description: This is Cytomegalovirus p150 recombinant antigen for ELISA,WB.

Cytomegalovirus IgG ELISA Kit
DEIA013	Creative Diagnostics	96T	EUR 858
Description: The CMV IgG ELISA is intended for use in the detection of Cytomegalovirus Antibody IgG in human serum.

Cytomegalovirus IgG ELISA Kit
DEIA326	Creative Diagnostics	96T	EUR 795.6
Description: Enzyme immunoassay for the quantitative determination of IgG antibodies against Cytomegalovirus in human serum and plasma.

Anti-Human Cytomegalovirus antibody
STJ16100451	St John's Laboratory	1 mL	EUR 1092

Anti-Cytomegalovirus p65 antibody
STJ16101049	St John's Laboratory	100 µg	EUR 424.8

Anti-Cytomegalovirus p65 antibody
STJ16101050	St John's Laboratory	100 µg	EUR 424.8

Anti-Cytomegalovirus p65 antibody
STJ16101051	St John's Laboratory	100 µg	EUR 424.8

Cytomegalovirus Antibody / CMV / PP65
V2332-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65
V2332-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65
V2332SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65
V2333-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65
V2333-20UG	NSJ Bioreagents	20 ug	EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65
V2333SAF-100UG	NSJ Bioreagents	100 ug	EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus (CMV) Chimeric 1 Protein
abx061513-1mg	Abbexa	1 mg	EUR 1796.4

Cytomegalovirus Envelope Glycoprotein H Antibody
20-abx109273	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug